Literature DB >> 28941117

Can reduced drinking be a viable goal for alcohol dependent patients?

Karl Mann1, Henri-Jean Aubin2,3, Katrin Charlet4, Katie Witkiewitz5.   

Abstract

Entities:  

Year:  2017        PMID： 28941117      PMCID： PMC5608854          DOI： 10.1002/wps.20476

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  4 in total

Review 1.  Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence.

Authors:  Jan van Amsterdam; Wim van den Brink
Journal:  J Psychopharmacol       Date:  2013-07-02       Impact factor: 4.153

2.  Drinking goal choice and outcomes in a Web-based alcohol intervention: results from VetChange.

Authors:  Justin L Enggasser; John A Hermos; Amy Rubin; Mark Lachowicz; Denis Rybin; Deborah J Brief; Monica Roy; Eric Helmuth; David Rosenbloom; Terence M Keane
Journal:  Addict Behav       Date:  2015-03       Impact factor: 3.913

3.  Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.

Authors:  Deborah S Hasin; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Rebecca L Robinson; Raymond Anton
Journal:  Lancet Psychiatry       Date:  2017-04-26       Impact factor: 27.083

4.  Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.

Authors:  Katie Witkiewitz; Kevin A Hallgren; Henry R Kranzler; Karl F Mann; Deborah S Hasin; Daniel E Falk; Raye Z Litten; Stephanie S O'Malley; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2016-12-26       Impact factor: 3.455
  4 in total
  9 in total

1.  Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population.

Authors:  Justin Knox; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel E Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Raymond Anton; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2019-05-29       Impact factor: 4.492

2.  Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.

Authors:  Justin Knox; Jennifer Scodes; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Raymond Anton; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2019-02-14       Impact factor: 4.492

Review 3.  Prevention, screening, and treatment for heavy drinking and alcohol use disorder.

Authors:  Justin Knox; Deborah S Hasin; Farren R R Larson; Henry R Kranzler
Journal:  Lancet Psychiatry       Date:  2019-10-17       Impact factor: 27.083

4.  Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease.

Authors:  Justin Knox; Jennifer Scodes; Katie Witkiewitz; Henry R Kranzler; Karl Mann; Stephanie S O'Malley; Melanie Wall; Raymond Anton; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2020-07-03       Impact factor: 3.455

5.  Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder.

Authors:  Corey R Roos; Charla Nich; Chung Jung Mun; Theresa A Babuscio; Justin Mendonca; André Q C Miguel; Elise E DeVito; Sarah W Yip; Katie Witkiewitz; Kathleen M Carroll; Brian D Kiluk
Journal:  Drug Alcohol Depend       Date:  2019-10-21       Impact factor: 4.492

6.  Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.

Authors:  Justin Knox; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Raymond Anton; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2018-10-03       Impact factor: 3.455

7.  Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.

Authors:  Erica N Grodin; Spencer Bujarski; Brandon Towns; Elizabeth Burnette; Steven Nieto; Aaron Lim; Johnny Lin; Karen Miotto; Artha Gillis; Michael R Irwin; Christopher Evans; Lara A Ray
Journal:  Transl Psychiatry       Date:  2021-06-12       Impact factor: 6.222

8.  Trajectories of alcohol misuse among the UK Armed Forces over a 12-year period.

Authors:  Laura Palmer; Sam Norton; Margaret Jones; Roberto J Rona; Laura Goodwin; Nicola T Fear
Journal:  Addiction       Date:  2021-07-20       Impact factor: 7.256

9.  A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation.

Authors:  Mehdi Farokhnia; Sara L Deschaine; Armin Sadighi; Lisa A Farinelli; Mary R Lee; Fatemeh Akhlaghi; Lorenzo Leggio
Journal:  Mol Psychiatry       Date:  2018-10-31       Impact factor: 15.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.